PlainRecalls
FDA Drug Moderate Class II Terminated

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30

Reported: August 14, 2013 Initiated: June 21, 2013 #D-840-2013

Product Description

MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30

Reason for Recall

Presence of Precipitate; potential for incomplete constitution upon addition of diluent.

Details

Units Affected
81,900 total vials
Distribution
USA and Puerto Rico
Location
Wilmington, DE

Frequently Asked Questions

What product was recalled?
MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30. Recalled by AstraZeneca Pharmaceuticals LP. Units affected: 81,900 total vials.
Why was this product recalled?
Presence of Precipitate; potential for incomplete constitution upon addition of diluent.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2013. Severity: Moderate. Recall number: D-840-2013.